BCM
TMO icon

BlueCrest Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

BlueCrest Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700
Closed -$407K – 220
2024
Q1 		$407K Sell
700
-15,600
-96% -$8.75M 0.02% 180
2023
Q4 		$8.65M Buy
+16,300
New +$7.89M 0.33% 60

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlueCrest Capital Management's TMO Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 2,542 shares — an estimated $1.43M sold.

BlueCrest Capital Management first reported a position in TMO in Q1 2015 and held it in 10 quarters. The position peaked at $1.45M in Q3 2023. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • BlueCrest Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 2,542 Thermo Fisher Scientific shares in Q1 2024, an estimated $1.43M.
  • BlueCrest Capital Management first reported a position in Thermo Fisher Scientific in Q1 2015 and held it in 10 quarters.
  • BlueCrest Capital Management's Thermo Fisher Scientific position peaked at $1.45M in Q3 2023.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.